Hims & Hers Health, Inc. — Form 8-K Summary
Business context and reporting period
Hims & Hers Health, Inc. furnished this Form 8-K on August 7, 2023, under Item 2.02 to announce results for the quarter ended June 30, 2023. The filing identifies the company’s Class A common stock as trading on the New York Stock Exchange under the symbol HIMS.
Financial results and key metrics
The filing states that a press release containing the quarterly results was furnished as Exhibit 99.1. The provided filing text does not include the press release’s underlying figures; therefore, revenue, profit or loss, cash flow, margins, debt, liquidity, and other financial metrics are not clearly provided.
Material changes versus the prior comparable period
The filing text does not provide sufficient financial data to determine changes versus the prior-year or prior-quarter comparable period.
Guidance, outlook, risks, and unusual items
No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the provided text. These matters may be addressed in Exhibit 99.1, but the exhibit’s contents are not included here.
Important facts to verify
- Review Exhibit 99.1 for quarterly revenue, subscribers, profitability, cash flow, balance-sheet liquidity, and margin information.
- Verify the company’s reported results against the prior comparable period.
- Check Exhibit 99.1 for updated full-year or subsequent-quarter guidance and management commentary.
- Confirm whether the quarterly results include material non-GAAP adjustments, unusual items, contingencies, or changes in debt and liquidity.